Evidence map›Paper›PMID 26951098›Full record

ReviewCurrent pharmaceutical design2016

Perspective on Nanoparticle Technology for Biomedical Use.

Ramesh Raliya, Tandeep Singh Chadha, Kelsey Haddad, Pratim Biswas

Abstract readReview
In one paragraph

Review in Current pharmaceutical design, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury.Central nervous system agents in medicinal chemistry · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Veterinary nanomedicine: Pros and cons.Veterinary medicine and science · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Applications of Metal-Organic Frameworks as Drug Delivery Systems.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Nanomaterials: Synthesis and Applications in Theranostics.Nanomaterials (Basel, Switzerland) · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ramesh Raliya
Tandeep Singh Chadha
Kelsey Haddad
Pratim BiswasSchool of Engineering and Applied Science, Washington University in St. Louis, St. Louis, MO-63130, USA. pbiswas@wustl.edu.

Funding

Project 2 - Radiation-Induced Treatment of Multiple Myeloma using NanoparticlesU54CA199092 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2019
$11.5M
NCI NIH HHS U54 CA199092
6 · The paper itself

Abstract

This review gives a short overview on the widespread use of nanostructured and nanocomposite materials for disease diagnostics, drug delivery, imaging and biomedical sensing applications. Nanoparticle interaction with a biological matrix/entity is greatly influenced by its morphology, crystal phase, surface chemistry, functionalization, physicochemical and electronic properties of the particle. Various nanoparticle synthesis routes, characterization, and functionalization methodologies to be used for biomedical applications ranging from drug delivery to molecular probing of underlying mechanisms and concepts are described with several examples (150 references).

Indexed as

Biomedical ResearchDrug Delivery SystemsNanotechnologyAnimalsHumansNanoparticlesParticle SizeSurface Properties

Identifiers

PMID26951098
PMCPMC4930863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.